E Paietta

Summary

Country: USA

Publications

  1. ncbi request reprint Expression of cell-surface antigens in acute promyelocytic leukaemia
    Elisabeth Paietta
    New York Medical College, Valhalla, NY, USA
    Best Pract Res Clin Haematol 16:369-85. 2003
  2. doi request reprint Minimal residual disease in acute myeloid leukemia: coming of age
    Elisabeth Paietta
    Albert Einstein College of Medicine, Bronx, NY, USA
    Hematology Am Soc Hematol Educ Program 2012:35-42. 2012
  3. doi request reprint Surrogate marker profiles for genetic lesions in acute leukemias
    Elisabeth Paietta
    Montefiore Medical Center North Division, Immunology Laboratory, Cancer Center, 600 East 233rd Street, Bronx, NY 10466, USA
    Best Pract Res Clin Haematol 23:359-68. 2010
  4. ncbi request reprint A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes
    E Paietta
    Immunology Laboratory, Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York 10466, USA
    Cytometry B Clin Cytom 59:1-9. 2004
  5. ncbi request reprint Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias
    Elisabeth Paietta
    Our Lady of Mercy Cancer Center Immunology Laboratory, 600 East 233rd St, Bronx, NY 10466, USA
    Blood 104:558-60. 2004
  6. ncbi request reprint Comments on the 2001 WHO proposal for the classification of haematopoietic neoplasms
    Elisabeth Paietta
    New York Medical College, Valhalla, NY, USA
    Best Pract Res Clin Haematol 16:547-59. 2003
  7. ncbi request reprint How to optimize multiparameter flow cytometry for leukaemia/lymphoma diagnosis
    Elisabeth Paietta
    Our Lady of Mercy Cancer Center, 600 East 233rd Street, 10466, Bronx, NY, USA
    Best Pract Res Clin Haematol 16:671-83. 2003
  8. ncbi request reprint Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York 10466, USA
    Am J Hematol 66:189-96. 2001
  9. ncbi request reprint Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY 10466, USA
    Leukemia 17:1544-50. 2003
  10. ncbi request reprint Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
    P H Wiernik
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY 10466, USA
    Leukemia 18:1605-10. 2004

Collaborators

Detail Information

Publications18

  1. ncbi request reprint Expression of cell-surface antigens in acute promyelocytic leukaemia
    Elisabeth Paietta
    New York Medical College, Valhalla, NY, USA
    Best Pract Res Clin Haematol 16:369-85. 2003
    ..Despite some significant antigenic differences (e.g. in CD34 expression), this surrogate marker profile for t(15;17) APL applies to both the M3 and the M3v FAB phenotypes and to all three isoforms of the PML/RARalpha transcript...
  2. doi request reprint Minimal residual disease in acute myeloid leukemia: coming of age
    Elisabeth Paietta
    Albert Einstein College of Medicine, Bronx, NY, USA
    Hematology Am Soc Hematol Educ Program 2012:35-42. 2012
    ....
  3. doi request reprint Surrogate marker profiles for genetic lesions in acute leukemias
    Elisabeth Paietta
    Montefiore Medical Center North Division, Immunology Laboratory, Cancer Center, 600 East 233rd Street, Bronx, NY 10466, USA
    Best Pract Res Clin Haematol 23:359-68. 2010
    ..As the list of therapeutic targets grows, the role of surrogate antigen profiles will grow, as they can predict for the efficacy of targeted approaches in lieu of expensive, time-consuming and not always accessible genetic analyses...
  4. ncbi request reprint A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes
    E Paietta
    Immunology Laboratory, Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York 10466, USA
    Cytometry B Clin Cytom 59:1-9. 2004
    ....
  5. ncbi request reprint Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias
    Elisabeth Paietta
    Our Lady of Mercy Cancer Center Immunology Laboratory, 600 East 233rd St, Bronx, NY 10466, USA
    Blood 104:558-60. 2004
    ..Our results indicate the need for clinical trials to test the efficacy of drugs that inhibit the FLT3 RTK in this subset of patients with T-ALL...
  6. ncbi request reprint Comments on the 2001 WHO proposal for the classification of haematopoietic neoplasms
    Elisabeth Paietta
    New York Medical College, Valhalla, NY, USA
    Best Pract Res Clin Haematol 16:547-59. 2003
    ..By introducing some state-of-the-art classification modalities, some of which are still awaiting confirmation, this chapter also aims to spark excitement and provide a glimpse at the future...
  7. ncbi request reprint How to optimize multiparameter flow cytometry for leukaemia/lymphoma diagnosis
    Elisabeth Paietta
    Our Lady of Mercy Cancer Center, 600 East 233rd Street, 10466, Bronx, NY, USA
    Best Pract Res Clin Haematol 16:671-83. 2003
    ....
  8. ncbi request reprint Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, New York 10466, USA
    Am J Hematol 66:189-96. 2001
    ..Epstein-Barr virus (EBV) sequences were detected in one T- and both B-lymphoid cases. Our data suggest that CD56 is expressed at a precursor stage common to the T- and the B-cell lineage...
  9. ncbi request reprint Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY 10466, USA
    Leukemia 17:1544-50. 2003
    ..Although not statistically significant, the observed association between low CD65s expression and decreased CR rate only in patients over the age of 55 is intriguing...
  10. ncbi request reprint Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
    P H Wiernik
    Our Lady of Mercy Cancer Center, New York Medical College, Bronx, NY 10466, USA
    Leukemia 18:1605-10. 2004
    ..025). This suggests that in a CLL population treated with theophylline, induction of an apoptotic response to the drug in vitro is prognostic for absence of clinical progression...
  11. ncbi request reprint Anticipation in familial chronic lymphocytic leukaemia
    P H Wiernik
    Comprehensive Cancer Center, Our Lady of Mercy Medical Center, New York Medical College, Bronx, NY 10466, USA
    Br J Haematol 113:407-14. 2001
    ..A significant difference was observed between the ages of onset of the child generation and the SEER population (P < 0.00001), but not between the parent generation and the SEER population. Anticipation characterizes familial CLL...
  12. ncbi request reprint Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept?
    E Paietta
    Our Lady of Mercy Cancer Center, New York Medical College, 600 East 233rd Street, Bronx, NY 10466, USA
    Bone Marrow Transplant 29:459-65. 2002
    ..This discussion intends to redefine MRD into some biologically relevant subcategories which may warrant their own independent terminology...
  13. ncbi request reprint Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide
    Y Sun
    Department of Oncology, Montefiore Medical Center, Bronx, NY, USA
    Leukemia 18:1258-69. 2004
    ..25 microM ATO stimulated limited atypical maturation. These findings suggest that AP-1060 will be useful for further assessing molecular elements involved in APL progression and drug response/resistance...
  14. ncbi request reprint Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern Cooperative Oncology Group
    Martin S Tallman
    Northwestern University Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Chicago, IL 60611, USA
    J Clin Oncol 22:1276-86. 2004
    ..This study was designed to compare the outcome of patients with M5 to that of other subtypes of AML, and to identify differences in M5a and M5b...
  15. ncbi request reprint Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia
    Adolfo A Ferrando
    Department of Pediatric Oncology, Dana Farber Cancer Institute Harvard School of Public Health, 44 Binney Street, Mayer 630, Boston 02115, MA, USA
    Lancet 363:535-6. 2004
    ..Furthermore, our findings lead to questions about whether stem-cell transplantation in first remission is necessary for effective treatment of patients in the low-risk subgroup of patients with TLX1 oncogene expression...
  16. ncbi request reprint Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997
    Michael R Grever
    Eastern Cooperative Oncology Group, Division of Hematology Oncology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
    J Clin Oncol 25:799-804. 2007
    ..1), and p53 mutations have been reported to predict the clinical course and overall survival of patients with chronic lymphocytic leukemia (CLL). In addition, ZAP-70 and Bcl-2 family proteins have been explored as predictors of outcome...
  17. ncbi request reprint Differential gene expression patterns and interaction networks in BCR-ABL-positive and -negative adult acute lymphoblastic leukemias
    Dejan Juric
    Division of Medical Oncology, Stanford University School of Medicine, Stanford, CA 94305 5151, USA
    J Clin Oncol 25:1341-9. 2007
    ..To identify gene expression patterns and interaction networks related to BCR-ABL status and clinical outcome in adults with acute lymphoblastic leukemia (ALL)...
  18. ncbi request reprint A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
    Jacob M Rowe
    Department of Hematology and Bone Marrow Transplantation, Rambam Medical Center and Technion, Haifa 31096 Israel
    Blood 103:479-85. 2004
    ..Priming with hematopoietic growth factor did not improve response when compared with placebo. Furthermore, delaying induction therapy in older adults may lead to a lower complete remission rate...